These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15485198)

  • 1. Immunogenicity of yeast-derived hepatitis B vaccine in Pakistani adults. 1990.
    Zuberi SJ; Lodi TZ; Hassan R; Alam SE
    J Pak Med Assoc; 2004 Aug; 54(8 Suppl):S61-2. PubMed ID: 15485198
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine against human hepatitis B. 1976.
    Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hillerman MR
    JAMA; 1996 Dec; 276(22):1793-5. PubMed ID: 8946889
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of hepatitis B vaccine.
    Beasley RP
    JAMA; 2009 Jul; 302(3):322-4. PubMed ID: 19602694
    [No Abstract]   [Full Text] [Related]  

  • 4. Developers of the hepatitis B vaccine.
    Braillon A
    JAMA; 2009 Dec; 302(23):2552; author reply 2552. PubMed ID: 20009054
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.
    Kulkarni PS; Raut SK; Patki PS; Phadke MA; Jadhav SS; Kapre SV; Dhorje SP; Godse SR
    Vaccine; 2006 Apr; 24(17):3457-60. PubMed ID: 16530299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery of the hepatitis B virus and the invention of the vaccine: a scientific memoir.
    Blumberg BS
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S502-3. PubMed ID: 12534787
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity of a plasma-derived hepatitis B vaccine in children and adults.
    Sinniah M; Halimah M; Krishnamurthy T; Lye MS; Choo CH; Shamsiah I
    Med J Malaysia; 1994 Dec; 49(4):336-40. PubMed ID: 7674968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the antigenicity and immunogenicity of a new hepatitis B vaccine using a panel of monoclonal antibodies.
    Waters JA; Bailey C; Love C; Thomas HC
    J Med Virol; 1998 Jan; 54(1):1-6. PubMed ID: 9443102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low response to hepatitis B virus vaccine in Costa Rican health-care workers.
    Taylor L; García Z; Herrera G; Luftig RB; Visona KA
    Hepatology; 1998 Feb; 27(2):637. PubMed ID: 9462669
    [No Abstract]   [Full Text] [Related]  

  • 10. The study of immune effect of nine kinds of recombinant hepatitis B vaccines made in China and foreign countries.
    Jing Q; Ren L; Wang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):349-51. PubMed ID: 11471023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
    Raz R; Koren R; Bass D
    Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunogenicity and efficacy of recombinant yeast derived hepatitis B vaccine for interruption of mother-infant transmission of hepatitis B virus.
    Zhu QR; Gu XH; Duan SC; Xu HF
    Chin Med J (Engl); 1994 Dec; 107(12):915-8. PubMed ID: 7882730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.
    Marinho RT; Ramalho F; Velosa J
    Hepatology; 1998 Oct; 28(4):1166. PubMed ID: 9841230
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults.
    Estévez ZC; Betancourt AA; Muzio González V; Baile NF; Silva CV; Bernal FH; Arias EP; Delhanty Fernández A; Olazábal NM; del Río Martín A; Batista LL; Véliz Ríos G; Hernández HH; Hernández AB; Lugo EP; de la Torre Cruz J; Batista Marchec BL; Falcón LA; Brito JT; León DO; Saura PL
    Biologicals; 2007 Apr; 35(2):115-22. PubMed ID: 17056272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
    Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A
    J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a recombinant, yeast-derived, anti-hepatitis-B vaccine after alternative dosage and schedule vaccination in Pakistani children.
    Akram DS; Maqbool S; Khan DS; Jafri R; Randhawa S; Valenzuela-Silva C; Lopez-Saura P
    Vaccine; 2005 Dec; 23(50):5792-7. PubMed ID: 16303217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The evaluation on immunogenicity of hepatitis B vaccine].
    Li HM; Liang ZL; Zhang HY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):378-81. PubMed ID: 15231155
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of a low dose of indigenously developed recombinant hepatitis-B vaccine in neonates and infants.
    Rao MN; Joshi N; Habibullah CM
    Indian Pediatr; 1999 Jun; 36(6):581-3. PubMed ID: 10736587
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in adults].
    Shi J; Wang X; Wang G; Xu Z; Yang Z; Zheng L; Li Z; Guo N; Wu X; Liang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Nov; 36(6):366-9. PubMed ID: 12641969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine formulation in healthy adults.
    Bulkow LR; McMahon BJ; Wainwright RB; Parkinson AJ; Wainwright KY; House J
    Arctic Med Res; 1993 Jul; 52(3):118-26. PubMed ID: 8397580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.